The Relative Strength (RS) Rating for HealthEquity stock jumped into a new percentile Tuesday, with a rise from 72 to 84.
When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.
This unique rating tracks technical performance by showing how a stock's price movement over the last 52 weeks compares to that of other stocks on the major indexes.
Over 100 years of market history shows that the stocks that go on to make the biggest gains tend to have an RS Rating of over 80 in the early stages of their moves.
Looking For Winning Stocks? Try This Simple Routine
Is HealthEquity Stock A Buy?
HealthEquity stock is working on a consolidation with a 79.20 entry. See if the stock can break out in heavy trading.
The health savings account custodian company showed 61% earnings growth in the latest quarterly report. Sales gains came in at 18%.
HealthEquity stock earns the No. 2 rank among its peers in the Commercial Services-Outsourcing industry group. HealthEquity and Crawford are also among the group's highest-rated stocks.
